Keywords: EPI; echo-planar imaging; FCA; functional connectivity analysis; GIFT; Group ICA for fMRI Toolbox; GLM; general linear models; ICA; independent component analysis; ICs; independent components; NBS; Network-Based Statistics; TDI; Threshold-Detection-Iden
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 11β-PGF2α; 11β-prostaglandin F2α; BHR; bronchial hyperresponsiveness; DHA; docosahexaenoic acid; EIB; exercise-induced bronchoconstriction; EPA; eicosapentaenoic acid; EVH; eucapnic voluntary hyperventilation; HEPE; hydroxyeicosapentaenoic acid; ICS;
Keywords: Asthma; Biologics; Therapeutics; AQLQs; Asthma quality of life questionnaires; EPR3; Expert Panel Report 3; FEV1; Forced expiratory volume in 1 second; FENO; Fractional exhaled nitric oxide; GM-CSF; Granulocyte-macrophage colony-stimulating factor; ICS;
Keywords: Asthma; Resource use; Outcomes; Comparative effectiveness; Propensity score; Treatment; ANCOVA; analysis of covariance; B/F; budesonide + formoterol; CI; confidence interval; F/S; fluticasone + salmeterol; ICD; international classification of diseases
Keywords: ACC; accuracy; ANOVA; analysis of variance; CNV; contingent negative variation; EEG; electroencephalogram; EOG; electrooculogram; ERPs; event-related potentials; ERSP; event-related spectral perturbation; ICs; independent components; WM; working memory; t
Keywords: ASAs; anticipatory synergy adjustments; DPMs; distributed processing modules; ICS; impaired control of stability; PD; Parkinson's disease; UCM; uncontrolled manifold; UPDRS; Unified PD Rating Scale; stability; synergy; anticipatory synergy adjustments;
Keywords: aOR; adjusted OR; ICS; inhaled corticosteroid; LABA; long-acting β-agonist; OCS; oral corticosteroid; PEF; peak expiratory flow;
Keywords: Asthma; Lung function; Macrolide; Meta-analysis; CNKI; China national knowledge internet; WMD; weighed mean difference; SMD; standardized mean difference; PEF; peak expiratory flow; AHR; airway hyper-responsiveness; FEV1/FVC; the ratio of forced expirator
Keywords: STSS; soft-shelled turtle systemic septicemia; STSSSV; soft-shelled turtle systemic septicemia spherical virus; ICS; immunochromatographic strip; IgY; egg yolk antibody; PcAb; polyclonal antibody; TNE; tris-EDTA-buffered saline with 12â° NaCl; PMSF; phen
Keywords: Asthma; T lymphocytes; cytokines; mast cells; phenotype; endotype; regulatory T; TH17; TH2; mucosal-associated invariant T-cell; ACQ; Asthma Control Questionnaire; BAL; Bronchoalveolar lavage; BNA; Bayesian network analysis; eNO; Exhaled nitric oxide; FOX
Keywords: Pregnancy; Asthma; Anti-asthmatic agents; Congenital abnormalities; Electronic medical records; Teratogens; BDP; Beclometasone dipropionate; CPRD; Clinical Practice Research Datalink; FP; Fluticasone propionate; FSC; Fluticasone propionate in fixed dose c
Keywords: SOT; solid organ transplantation; OI; opportunistic infections; HCMV; human cytomegalovirus; EBV; Epstein-Barr virus; BKV; polyoma BK virus; KTR; kidney transplant recipients; LTR; lung transplant recipients; BAL; bronchoalveolar lavage; ATP; adenosine tr
Keywords: Asthma; asthma control; budesonide/formoterol maintenance and reliever therapy; exacerbations; Global Initiative for Asthma; predictors; risk score; ACQ-5; 5-Item Asthma Control Questionnaire; ADAS; Asthma Disease Activity Score; BMI; Body mass index; BUD
Keywords: Asthma; asthma control; asthma exacerbations; dupilumab; biomarkers; inhaled corticosteroids; lebrikizumab; long-acting Ã-adrenergic agonists; mepolizumab; omalizumab; reslizumab; severe asthma; therapeutics; ACQ; Asthma control questionnaire; BADGER; Be
Keywords: Asthma phenotypes; biologic therapies; eosinophils; IgE; IL-4; IL-5; IL-13; TH2/type 2 inflammation; ACQ; Asthma Control Questionnaire; DBPC; Double-blind, placebo-controlled; FDA; US Food and Drug Administration; Feno; Fraction of exhaled nitric oxide; I
Keywords: Asthma; seasons; biomarkers; asthma exacerbations; IgE; exhaled nitric oxide; allergy; eosinophils; pulmonary function; ACE; Asthma Control Evaluation; BMI; Body mass index; Feno; Fraction of exhaled nitric oxide; FVC; Forced vital capacity; ICATA; Inner
Keywords: Corticosteroids; bronchodilator; cytokine; chemokine; IgE; kinase; p38 mitogen-activated protein kinase; bronchial thermoplasty; corticosteroid resistance; macrolide; ACOS; Asthma-chronic obstructive pulmonary disease overlap syndrome; COPD; Chronic obs
Keywords: Asthma; bone mineral density; child; corticosteroids; APPL1; Adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1; BMA; Bone mineral accretion; BMD; Bone mineral density; CAMP; Childhood Asthma Management Program; eQTL;
Keywords: Asthma; health care; insurance claim review; pregnancy; ED; Emergency department; ICD-10; International Classification of Diseases, 10th revision; ICS; Inhaled corticosteroid; ICU; Intensive care unit; LABA; Long-acting β2-agonist; NHI; National Health I
Keywords: 8-IP; 8-isoprostane; A1A; α1-antitrypsin; A1AD; α1-antitrypsin deficiency; AEP; acute eosinophilic pneumonia; AMP; antimicrobial peptide; CRS; chronic rhinosinusitis; CS; cigarette smoke; DI; deletion/insertion; DIP; desquamative interstitial pneumonia;
Keywords: ICS; inhaled corticosteroid; IP; inpatient admission; OLDW; Optum Laboratories Data Warehouse; SCS; systemic corticosteroid;
Keywords: Virus; rhinovirus; asthma; asthma control; children; mixed-model analysis; respiratory; c-ACT; Childhood Asthma Control Test; CCQ; Common Cold Questionnaire; GAPDH; Glyceraldehyde-3-phosphate dehydrogenase; HDM; House dust mite; hRV; Human rhinovirus; ICS
Keywords: BNNT; boron nitride nanotube; CNT; carbon nanotube; CR; concentration ratio; CRS; central receiver system; CSP; concentrated solar power; DC; direct current; ETC; evacuated tube collector; ICS; integrated collector storage; LDR; light dependent resistor;
Keywords: Asthma; Childhood; Small-particle beclomethasone; Fluticasone; Inhaled corticosteroid; Long-acting β2-agonist; Step-up therapy; adjOR; adjusted odds ratio; adjRR; adjusted rate ratio; GP; general practice; ICS; inhaled corticosteroid; LABA; long-acting Î
Keywords: Fluticasone propionate/salmeterol combination; Fluticasone propionate; Asthma exacerbation; Human rhinovirus; Upper respiratory tract infection; AE; adverse event; C-ACT; Childhood Asthma Control Test; ER; emergency room; FP/SAL; fluticasone propionate/sa
Keywords: Asthma; bronchial provocation tests; eosinophils; exhaled nitric oxide; occupational diseases; sputum; AHR; Airway hyperresponsiveness; Feno; Fractional exhaled nitric oxide; HMW; High molecular weight; ICS; Inhaled corticosteroid; LMW; Low molecular weig
Keywords: AIR; Asthma Intervention Research; AQLQ; Asthma Quality of Life Questionnaire; ASM; airway smooth muscle; FDA; US Food and Drug Administration; ICS; inhaled corticosteroid; PPS; posterior probability of success; QOL; quality of life;
Keywords: Asthma; Hospitalizations; Mortality; Costa Rica; COPD; Chronic obstructive pulmonary disease; HNN; Hospital Nacional de Niños; ICS; Inhaled corticosteroids; NAP; National Asthma Program;
Keywords: ED; Emergency department; HEDIS; Healthcare Effectiveness Data and Information Set; ICD-9; International Classification of Diseases, 9th revision; ICS; Inhaled corticosteroid; LTRA; Leukotriene receptor antagonist; LTRAM; Leukotriene receptor antagonist m
Keywords: FEF25-75; Forced expiratory flow rate at 25%-75%; FeNO; Fractional exhaled nitric oxide; FEV1; Forced expiratory volume in 1 second; FVC; Forced vital capacity; HDM; House dust mite; ICS; Inhaled corticosteroids;
Keywords: polyuria; nocturia; review; ICS; International Continence Society; NP; nocturnal polyuria; NPi; nocturnal polyuria index; NUP; nocturnal urine production; NVF; nocturnal voiding frequency;
Keywords: Asthma; Exacerbations; Natural history; Inhaled corticosteroids; Long-acting β-agonists; COPD; Chronic obstructive pulmonary disease; ED; Emergency department; HI; High-intensity asthma treatment; CD-9; International Classification of Diseases, Ninth Rev
Keywords: CPB; cardiopulmonary bypass; ICS; intercostal space; MCL; midclavicular line; MR; mitral valve regurgitation; MVP/rMVP; mitral valve repair/robotic mitral valve repair; PTFE; polytetrafluoroethylene; SD; standard deviation; STS; Society of Thoracic Surgeo
Keywords: CVA; cough variant asthma; ICS; inhaled corticosteroid; NIC; nonspecific isolated cough;
Keywords: ICS; inhaled corticosteroid; LOS; length of stay;
Keywords: Bronchial asthma; Sputum induction; ICS; Sputum cell count
Keywords: Stadiometry; Children; Intranasal corticosteroid; 24-Hour urinary cortisol; Randomized clinical trial; Placebo controlled; FFNS; Fluticasone furoate nasal spray; ICS; Inhaled corticosteroid; INS; Intranasal corticosteroid; ITT; Intent-to-treat population;
Keywords: Asthma; Controller medications; Effectiveness; Inhaled corticosteroids; Leukotriene antagonist; Long-acting β-agonist; ED; Emergency department; hdPS; High-dimensional propensity score; HPHC; Harvard Pilgrim Health Care; HR; Hazard ratio; ICS; Inhaled co
Keywords: Asthma; Wheezing; Childhood; Virus; API; Asthma Predictive Index; EGA; Estimated gestational age; RV; Human rhinovirus; ICS; Inhaled corticosteroids; mAPI; Modified Asthma Predictive Index; RSV; Respiratory syncytial virus;
Keywords: Asthma; Anti-asthmatic agents; Step down; Withdraw; Discontinue; Decrease; Wean; Cessation; ICS; Inhaled corticosteroid; LABA; Long-acting β-agonist; LTRA; Leukotriene receptor antagonist; RCT; Randomized controlled trial;
Keywords: ICS; Standardization; Reproducibility; Rare events; Positivity; Automated analysis;
Keywords: Airway remodeling; asthma; asthma control; asthma exacerbations; early intervention in asthma; biomarkers; environment; genetics; inhaled corticosteroids; leukotriene receptor antagonists; long-acting β-adrenergic agonists; personalized medicine; severe
Keywords: Asthma; adults; inhaled corticosteroids; asthma management; ACQ; Asthma Control Questionnaire; CalvNO; Alveolar fraction of exhaled nitric oxide; COPD; Chronic obstructive pulmonary disease; CRTH2; Chemoattractant receptor homologous molecule expressed on
Keywords: Clusters; outcomes; prospective study; exacerbation; ACQ-6; 6-Item Asthma Control Questionnaire; ICS; Inhaled corticosteroid; LABA; Long-acting β2-agonist; OCS; Oral corticosteroid; SARP; Severe Asthma Research Program;
Keywords: FOT; forced oscillation technique; ICC; intraclass correlation coefficient; ICS; inhaled corticosteroid; PEF; peak expiratory flow; Rrs; respiratory system resistance; SDW; within-subject SD; Xrs; respiratory system reactance;
Keywords: Airflow limitation; Airway inflammation; Atopy; Exhaled nitric oxide; Inhaled corticosteroids; Nasal corticosteroids; ACQ; Asthma Control Questionnaire; AR; Allergic rhinitis; ARIA; Allergic Rhinitis and its Impact on Asthma; FVC; Forced vital capacity; F
Keywords: ARDS; acute respiratory distress syndrome; CAP; community-acquired pneumonia; COPD; chronic obstructive pulmonary disease; ICS; inhaled corticosteroid; LIPS; Lung Injury Prediction Score; OR; odds ratio;
Keywords: ICS; Antigen specific; Proficiency testing; Flow cytometry; Site performance; Grading;
Keywords: asthma; Severe asthma; Asthma control; Asthma management; Prescription data; ACE; Angiotensin-converting-enzyme; COPD; Chronic obstructive pulmonary disease; ED; Emergency department; GP; General practitioner; ICS; Inhaled corticosteroid; ICS-LABA; Fixed-
Keywords: Asthma; inflammatory phenotypes; gene expression; induced sputum; neutrophils; eosinophils; ACQ; Asthma Control Questionnaire; ALPL; Alkaline phosphatase, tissue-nonspecific isozyme; AUC; Area under the curve; BIRC3; Baculoviral IAP repeat containing 3; B